Aptar’s Eye Care Solutions Designed to Improve Dosing Precision, Including Newest Technology, Beat the Blink™
Aptar shared an overview of its growing portfolio of eye care solutions including its new technology, Beat the Blink™, a delivery system designed to improve dosing precision and enhance patient experience by “beating the blink” reflex, currently part of an exclusive partnership with Bausch and Lomb.
Crystal Lake, Illinois, January 12, 2026 —AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery and consumer product dosing, dispensing and protection technologies, today shared an overview of its growing portfolio of eye care solutions including its new technology, Beat the Blink™, a delivery system designed to improve dosing precision and enhance patient experience by “beating the blink” reflex, currently part of an exclusive partnership with Bausch and Lomb. With over 500 market references, Aptar’s innovative and growing portfolio of eye care solutions is a go-to platform for ophthalmic drug delivery.
Avoiding preservatives in eye care formulations may help to make treatments more tolerable. As such, preservative-free multidose systems (PFMD) are gaining more importance for topical ophthalmic treatment applications. Whether these treatments are for prescribed drugs or over-the-counter drugstore products, the microbiological integrity of the PFMD is crucial. Aptar’s portfolio of market-leading ophthalmic delivery systems is designed to meet the key needs of patients for safe, precise eye care delivery. With over 500 market references, Aptar’s innovative and growing portfolio of eye care solutions is a go-to platform for ophthalmic drug delivery. This portfolio includes:
Beat the Blink™ 
Beat the Blink is a new eye care delivery system designed to improve dosing precision and enhance patient experience by “beating the blink” reflex. Aptar’s technology aims to address an unmet need: improving consumer experience by eliminating the need to tilt the head, which may cause targeting errors leading to insufficient administration of eye drops.
Key features include horizontal drop delivery and formula protection through a tip seal for preservative-free formulations. Additionally, the design of Beat the Blink is intended to ensure compliance with regulatory and quality requirements for ophthalmic solutions, incorporating a child-resistant concept, new bottle and ventilation design, microbial safety measures and intended compatibility with a wide range of eye care formulations. This technology is currently part of an exclusive partnership with Bausch and Lomb, a leading global eye care company, and commercial availability is expected to follow the completion of development and industrialization (estimated 24 to 36 months).
Ophthalmic Squeeze Dispenser 
Aptar’s Ophthalmic Squeeze Dispenser (OSD) is a leading preservative-free multidose eye dropper worldwide. The Ophthalmic Squeeze Dispenser utilizes a purely mechanical Tip-Seal technology that has been developed for use without preservatives and additives such as silver ions or surface coating. Aptar’s patented Tip-Seal technology has been tested by microbial challenge procedures simulating relevant in-use scenarios (however, customer formulations will require additional testing). Aptar provides a set of data and test methods for the Ophthalmic Squeeze Dispenser which are designed to help support pharmaceutical customers in preparing their finished product dossier.
APF Advanced Preservative Free
Aptar’s Advanced Preservative Free and its Advanced Preservative Free PLUS pumps, which add dermal, oral and eye care to the preservative-free offering, constitute an innovative spray dispensing system for nasal and topical applications that provide microbiological protection and stability for sensitive formulations using purely mechanical means and granting a metal-free fluid path. Aptar’s APF Futurity™ recyclable system represents the first metal free, all plastic multidose nasal spray system rated as highly recyclable by cyclos-HTP.
Digital Healthcare Solutions
Aptar offers a broad range of innovative digital healthcare solutions for the prevention, diagnosis and treatment of diseases, including patient monitoring and healthcare management. All of Aptar’s digital healthcare solutions, including for eye care, are patient-friendly, easy-to-use, intuitive and available as fully integrated technologies or extensions.
“Our extensive R&D capabilities, new systems development and customizable solutions allow us to offer a leading range of eye care solutions designed to improve dosing precision and enhance the patient and consumer experience,” said Gael Touya, President, Aptar Pharma. “Our partnership approach and suite of services help our customers meet evolving needs in eye care and navigate the challenges associated with developing both prescription and over-the-counter treatments.”
